MarketScreener Strategies Alnylam Pharmaceuticals, Inc.

Equities

Real-time Estimate Cboe BZX Other stock markets 18:00:33 24/06/2025 BST			5-day change	1st Jan Change
322.75 ^USD	+3.07%		+4.33%	+36.87%

06-18	Alnylam Announces Promotion of Pushkal Garg as Executive Vice President and Chief Research and Development Officer	CI
06-09	Alnylam Pharmaceuticals, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-09-2025 09:20 AM

No results for this search